PropertyValue
?:abstract
  • This document aims to provide practical guidance for the assessment and management of patients with thrombocytopenia, with a particular focus on immune thrombocytopenia (ITP), during the COVID‐19 pandemic. The intention is to support clinicians and, although recommendations have been provided, it is not a formal guideline. Nor is there sufficient evidence base to conclude that alternative approaches to treatment are incorrect. Instead, it is a consensus written by clinicians with an interest in ITP or coagulation disorders and reviewed by members of the UK ITP forum.
?:creator
?:doi
  • 10.1111/bjh.16775
?:doi
?:journal
  • Br_J_Haematol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/9e1a2673693ad6ea3a610d9e30ce2bd2d0d9b263.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7267627.xml.json
?:pmcid
?:pmid
?:pmid
  • 32374026.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Practical guidance for the management of adults with immune thrombocytopenia during the COVID‐19 pandemic
?:type
?:year
  • 2020-06-02

Metadata

Anon_0  
expand all